Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.stem.2013.11.013
Title: Oversight for clinical uses of autologous adult stem cells: Lessons from international regulations
Authors: Lysaght, T. 
Kerridge, I.
Sipp, D.
Porter, G.
Capps, B.J. 
Issue Date: 5-Dec-2013
Citation: Lysaght, T., Kerridge, I., Sipp, D., Porter, G., Capps, B.J. (2013-12-05). Oversight for clinical uses of autologous adult stem cells: Lessons from international regulations. Cell Stem Cell 13 (6) : 647-651. ScholarBank@NUS Repository. https://doi.org/10.1016/j.stem.2013.11.013
Abstract: Autologous adult stem cells (ASCs) are being administered by physicians for indications that have not been demonstrated as safe and effective in formal clinical trials. Examination of regulatory frameworks across five countries suggests that balancing the demands of research with clinical freedom has created structural weaknesses that are being exploited. © 2013 Elsevier Inc.
Source Title: Cell Stem Cell
URI: http://scholarbank.nus.edu.sg/handle/10635/125342
ISSN: 19345909
DOI: 10.1016/j.stem.2013.11.013
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

18
checked on Dec 2, 2021

WEB OF SCIENCETM
Citations

21
checked on Dec 2, 2021

Page view(s)

104
checked on Dec 2, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.